In this study, we showed that the level of activation of algorithmicallyreconstructed ERK1/2 signaling pathways may be an effective prognostic andpredictive cancer biomarker, with its prognostic value and significancedepending strongly on cancer type and the type of therapy. This evidence concerns the gene MAPK3 and cancer.